Development of Virtual Reality programs to reduce loneliness and social isolation among older people

Research on the development of Virtual Reality programs to reduce loneliness and social isolation among older people - Impact of reducing loneliness with VR

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000052667

Enrollment

Registered

2023-11-01

Start date

2023-10-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment, Subjective Cognitive Decline

Interventions

The first group will participate in the VR program once a month from 1-6 months after the start, and the observation period will be from 7-12 months. 6 times in total (once a month) will be scheduled

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients seen between the date of approval and March 31, 2024. 2. Patients who are able to obtain written consent for participation in the study of their own free will and whose cognitive function is not pathological (including SCD and MCI) 3. Patients who are 60 years of age or older at the time of obtaining consent 4. Gender: any gender 5. Inpatient/outpatient: Not applicable 6. Patients attending Kyoto Prefectural University of Medicine Hospital Medical Center for Dementia Diseases

Exclusion criteria

Exclusion criteria: (1) Patients with insufficient ability to speak and understand Japanese (2) Other patients who are deemed inappropriate by the physician in charge. (3) Those with a history of mental illness, head trauma, drug or alcohol abuse, those with significant visual or hearing impairment, and those who cannot use both hands.

Design outcomes

Primary

Measure	Time frame
Loneliness (UCLA Loneliness Scale (2nd Edition))	—

Secondary

Measure	Time frame
1. patient background: age, gender, educational history, dominant hand, and medical history are evaluated by interview. 2.Brain imaging: brain MRI images, SPECT scan 3.Cognitive function test: Mini Mental State Examination (MMSE) 4.Evaluation of psychiatric symptoms: Geriatric Depression Scale (GDS), Mild behavioral impairment-checklist (MBI-C) 5. Dementia severity: Clinical Dementia Rating (CDR) 6. Assessment of ADL: Instrumental activities of daily living (IADL), Physical Self-Maintenance Scale (PSMS) 7. Satisfaction and evaluation of the VR program 8. blood pressure and pulse rate before and after the program 9. evaluation of VR sickness: The Simulator Sickness Questionnaire (SSQ) 10. mood states before and after the program: Profile of Mood States (POMS)	—

Measure

Time frame

1. patient background: age, gender, educational history, dominant hand, and medical history are evaluated by interview. 2.Brain imaging: brain MRI images, SPECT scan 3.Cognitive function test: Mini Mental State Examination (MMSE) 4.Evaluation of psychiatric symptoms: Geriatric Depression Scale (GDS), Mild behavioral impairment-checklist (MBI-C) 5. Dementia severity: Clinical Dementia Rating (CDR) 6. Assessment of ADL: Instrumental activities of daily living (IADL), Physical Self-Maintenance Scale (PSMS) 7. Satisfaction and evaluation of the VR program 8. blood pressure and pulse rate before and after the program 9. evaluation of VR sickness: The Simulator Sickness Questionnaire (SSQ) 10. mood states before and after the program: Profile of Mood States (POMS)

—

Countries

Japan

Contacts

Public ContactImai Ayu

Graduate School of Medical Science, Kyoto Prefectural University of Medicine Department of Psychiatry

imaiayu@koto.kpu-m.ac.jp0752515612

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026